Los investigadores descubrieron que los participantes del ensayo que tomaron semaglutida redujeron su riesgo de morir por COVID-19 en un 34%, en comparacin con los pacientes que tomaron un placebo
Licensed Provider Oversight Every treatment plan is created and monitored by board-certified providers
Sands BE, Peyrin-Biroulet L, Kierkus J, Higgins PDR, Fischer M, Jairath V, Hirai F, DHaens G, Belin RM, Miller D, Gomez-Valderas E, Naegeli AN, Tuttle JL, Pollack PF, Sandborn WJ (2022) Efficacy and safety of mirikizumab in a randomized phase 2 study of patients with Crohns disease
PMid:19250794
B.ChenZ
Injectable medication and its needles are allowed in hand luggage, and the usual liquid limits dont apply